SEC Form 4 · accession 0001171843-15-006412
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew P Smith
Officer — Chief Financial Officer
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Nov 16, 2015 | P | 1,605 | $17.03 | A | 1,605 | D |
Table II — derivative securities
No Table II lines on this filing.